Phosphorus today announced it received FDA emergency use authorization for its COVID-19 saliva test for at-home sample collection.
The test is the second at-home unsupervised saliva test approved by the FDA so far, according to the company. It is available by ordering online and is available through healthcare and employer partnerships.
Saliva tests are simple and less intrusive in comparison to other swab-based methods. To order the tests, consumers must choose and order the test through an online checkout process and complete a medical questionnaire where an independent physician will review the medical information. Once approved, a sample collection kit will be shipped to the consumer’s home. Test results will be available within 72 hours after the laboratory receives the sample and will be accompanied by a consultation from medical personnel.
Phosphorous also said it is partnering with healthcare facilities and employers to conduct COVID-19 testing while eliminating exposure risks.
“COVID testing is essential to getting life back to normal. This test will allow people from coast to coast to be tested from the safety of their homes with the oversight of medical personnel,” said Alexander Bisignano, co-founder and CEO of Phosphorus. “We thank the FDA for their hard work throughout this crisis and the quick action they have taken. We look forward to helping the country re-open.”
The company said it is in full compliance with FDA guidelines for diagnostic tests for Coronavirus Disease-2019 during a public health emergency and has submitted validation data under the FDA’s emergency use authorization authority.